VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > VPT and COVID

<< Previous

Bullboard Posts

Next >>

Comment by Lieob007on Mar 28, 2021 6:17pm

249 Views

Post# 32895823

RE:VPT and COVID

Everytime when the VPT stock price decreased, I saw your post, good try. In another stock I Owned, I see someone bashed it every day, then the price increased from 0.2 to 2 within several months. I see the potential for VPT, the stock price will increase from 0.07 to 0.7 soon. Thank you for that, good time for longs to get cheaper shares.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale